Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Drug Innovation and Design Inc.
Drug Innovation and Design Inc.
Drug Delivery; Cancer-selective delivery; topical delivery of antivirals. DIAD's topical herpes treatment is a lipophilic prodrug involving a chemically-modified version of acyclovir. For cancer, DIAD is developing a way to selectively target cancerous cells based on the ratio of tumor-associated enzymes to enzymes found in all cells.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice